Here are today’s price and volume news makers together with updates to the BioPharmCatalyst Pipeline Database
Welcome to the NEW BioPharmCatalyst + CLVS granted priority review for Rucaparib
Welcome to the first Daily Newsletter from the revamped BioPharmCatalyst. Today’s tickers to make the news include TLOG, CLVS, STML, NWBO, REPH and SPHS.
PFE acquisition of MDVN spikes interest in small cap biostocks
Pfizer Inc. (NYSE:PFE) and Medivation, Inc. (NASDAQ:MDVN) sparked much frenzy among small/mid cap biostocks today following the acquisition of MDVN by PFE.
DVAX Advisory Committee Meeting scheduled for November 16, 2016
Dynavax Technologies Corporation (NASDAQ:DVAX) announcement that their Biologics License Application (BLA) for HEPLISAV-B for the treatment of Hepatitis B Vaccine will face an Advisory Committee on November 16, 2016. Other tickers included are PTCT APRI RIGL and MNTA.